Overcome tumor relapse in CAR T cell therapy Cheng-Dong HuoJie YangYu-Min Li Review Article 09 June 2022 Pages: 1833 - 1843
Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis Chandra Prakash PrasadAjay GogiaAtul Batra Review Article 25 June 2022 Pages: 1844 - 1855
CDC7 as a novel biomarker and druggable target in cancer Runze LiuYong Huang Review Article 03 June 2022 Pages: 1856 - 1864
Glycosylation and its research progress in endometrial cancer Congli PuBiyuanYingchao Zhao Review Article Open access 25 June 2022 Pages: 1865 - 1880
The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target Somayeh VafaeiHamed TaheriFiroozeh Abolhasani Zadeh Review Article 10 June 2022 Pages: 1881 - 1889
Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology José TrigoMónica García-CosíoMargarita Alberola-Ferranti Special Article Open access 23 June 2022 Pages: 1890 - 1902
Diagnostic impact of 18F-FDG PET/CT imaging on the detection of immune-related adverse events in patients treated with immunotherapy Gamze TatarGöksel AlçinTevfik Fikret Cermik Research Article 20 May 2022 Pages: 1903 - 1913
Effect of PPP1R14D gene high expression in lung adenocarcinoma knocked out on proliferation and apoptosis of DMS53 cell Ye TianLiguo GuanZexin Gu Research Article 17 May 2022 Pages: 1914 - 1923
Cell-free circulating tumor DNA in colorectal cancer: a proof of concept with simplified methodology Javier BosqueCarlos GuiraoJavier Gallego Plazas Research Article 02 May 2022 Pages: 1924 - 1931
Spinal cord compression of neoplastic origin: surgical experience using a common clinical language Oscar GodinoIgnacio VisusArturo Navarro-Martin Research Article 02 June 2022 Pages: 1932 - 1939
MiR-6511b-5p suppresses metastasis of pMMR colorectal cancer through methylation of CD44 by directly targeting BRG1 JinMing SunLing YeBingYu Qin Research Article Open access 19 May 2022 Pages: 1940 - 1953
FOXD2-AS1 acts an oncogene in esophageal squamous cell carcinoma through sponging miR-204-3p Dongbo LuoAdili SalaiYunfei Gao Research Article 01 July 2022 Pages: 1954 - 1963
FJX1 as a candidate diagnostic and prognostic serum biomarker for colorectal cancer Lei LiuYecai HuangYuanbiao Guo Research Article 01 June 2022 Pages: 1964 - 1974
Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors Chang LiuZhenxing WangShaofeng Duan Research Article 06 June 2022 Pages: 1975 - 1985
Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer Junqun LiaoYuan YeXuren Xu Research Article 23 June 2022 Pages: 1986 - 1997
HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC Xiaoyan WangYun ZhouHuiqin Quan Research Article 29 June 2022 Pages: 1998 - 2009
Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group Manuel Sánchez CánovasDavid Fernández GarayAndrés Jesús Muñoz Martín Research Article Open access 06 June 2022 Pages: 2010 - 2020
MiR-507 inhibits the progression of gastric carcinoma via targeting CBX4-mediated activation of Wnt/β-catenin and HIF-1α pathways Xin FangAnping Pan Research Article 11 July 2022 Pages: 2021 - 2028
Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma Qiwei ZhangWeiwei RuiXiaoyi Ding Research Article 22 June 2022 Pages: 2029 - 2038
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience Giulio FrancoliniRiccardo CampiLorenzo Livi Brief Research Article Open access 23 June 2022 Pages: 2039 - 2043
Correction to: Emerging roles of JMJD3 in cancer Maryam FarzanehZeinab KuchakiOmid Anbiyaee Correction 05 July 2022 Pages: 2044 - 2044